• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
JYSZ2300047 达雷妥尤单抗注射液 daratumumab Injection Biological Products License Renew 2023-10-31 Cilag AG;Xian Janssen Pharmaceutical Ltd;Janssen-Cilag AG view
CXSL2200528 达雷妥尤单抗注射液 daratumumab Injection Biological Products(3.3) New Drug Application 2022-10-20 Nanjing Shunxin Pharmaceuticals Co LTDof Chiatai Tianqing Pharmaceutical Group view
JYSB2000066 达雷妥尤单抗注射液 daratumumab Injection Biological Products Supplementary Application 2020-02-29 Janssen-Cilag International NV Janssen-Cilag International NV;Cilag AG Filed 2020-03-05 view
JYSB2500003 达雷妥尤单抗注射液 daratumumab Injection Biological Products Supplementary Application 2025-01-03 Cilag AG;Janssen-Cilag AG view
CXSL2300110 达雷妥尤单抗注射液 daratumumab Injection Biological Products(3.3) New Drug Application 2023-02-09 Hangzhou Jiuyuan Genetic Biopharmaceutical Co Ltd view
JYSB2000518 达雷妥尤单抗注射液 daratumumab Injection Biological Products Supplementary Application 2020-10-16 Janssen-Cilag International NV Janssen-Cilag International NV;Cilag AG Certificate Issued 2020-11-23 view
JYSB2300079 达雷妥尤单抗注射液 daratumumab Injection Biological Products Supplementary Application 2023-04-29 Cilag AG;Janssen-Cilag AG view
JYSB2101129 达雷妥尤单抗注射液 daratumumab Injection Biological Products Supplementary Application 2021-09-13 Cilag AG;Janssen-Cilag International NV view
JYSB2400094 达雷妥尤单抗注射液 daratumumab Injection Biological Products Supplementary Application 2024-04-25 Cilag AG;Janssen-Cilag AG view
JYSB2101145 达雷妥尤单抗注射液 daratumumab Injection Biological Products Supplementary Application 2021-10-11 Cilag AG;Janssen-Cilag International NV view
JYSB2000285 达雷妥尤单抗注射液 daratumumab Injection Biological Products Supplementary Application 2020-06-19 Janssen-Cilag International NV Janssen-Cilag International NV;Cilag AG Filed 2020-06-23 view
JXSS2100015 达雷妥尤单抗注射液 daratumumab Injection Biological Products(3.1) Import Drug Application 2021-02-19 西安杨森制药有限公司 Xian Janssen Pharmaceutical Ltd;Cilag AG;Janssen-Cilag International NV Certificate Issued 2021-11-12 view
JYSB2500002 达雷妥尤单抗注射液 daratumumab Injection Biological Products Supplementary Application 2025-01-03 Cilag AG;Janssen-Cilag AG view
CXSL2200529 达雷妥尤单抗注射液 daratumumab Injection Biological Products(3.3) New Drug Application 2022-10-20 Nanjing Shunxin Pharmaceuticals Co LTDof Chiatai Tianqing Pharmaceutical Group view
JXSS2000019 达雷妥尤单抗注射液 daratumumab Injection Biological Products Import Drug Application 2020-07-03 Janssen-Cilag International NV Janssen-Cilag International NV;Cilag AG In Review 2020-07-02 view
JYSB2300078 达雷妥尤单抗注射液 daratumumab Injection Biological Products Supplementary Application 2023-04-29 Cilag AG;Janssen-Cilag AG view
CXSL2400135 达雷妥尤单抗注射液 daratumumab Injection Biological Products(3.3) New Drug Application 2024-02-21 Nanjing Shunxin Pharmaceuticals Co LTDof Chiatai Tianqing Pharmaceutical Group view
JYSB2200005 达雷妥尤单抗注射液 daratumumab Injection Biological Products Supplementary Application 2022-01-07 Cilag AG;Janssen-Cilag AG view
JYSB2000086 达雷妥尤单抗注射液 daratumumab Injection Biological Products Supplementary Application 2020-03-18 Janssen-Cilag International NV Janssen-Cilag International NV;Cilag AG Filed 2020-03-26 view
JXSS2100016 达雷妥尤单抗注射液 daratumumab Injection Biological Products(3.1) Import Drug Application 2021-02-19 西安杨森制药有限公司 Xian Janssen Pharmaceutical Ltd;Cilag AG;Janssen-Cilag International NV Certificate Issued 2021-11-12 view